Cargando…

Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative

BACKGROUND: Traditional clinical trials are often expensive, inefficient, include selected populations, and can create significant participant burden via travel and other logistical demands. Using new technologies and methodologies to promote a decentralized approach has the potential to improve the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Apostolaros, Maria, Babaian, David, Corneli, Amy, Forrest, Annemarie, Hamre, Gerrit, Hewett, Jan, Podolsky, Laura, Popat, Vaishali, Randall, Penny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362888/ https://www.ncbi.nlm.nih.gov/pubmed/32557302 http://dx.doi.org/10.1007/s43441-019-00006-4

Ejemplares similares

From a decentralized clinical trial to a decentralized and clinical-trial-in-a-box platform: Towards patient-centric and equitable trials
por: Dulko, Dorothy, et al.
Publicado: (2023)

191 Ethical Considerations of Decentralized Clinical Trials
por: Pascalev, Assya
Publicado: (2022)

Assessing the Financial Value of Decentralized Clinical Trials
por: DiMasi, Joseph A., et al.
Publicado: (2022)

Improving and sustaining the site investigator community: Recommendations from the Clinical Trials Transformation Initiative
por: Fordyce, Christopher B., et al.
Publicado: (2019)

Decentralized Clinical Trials: The Future of Medical Product Development?∗
por: Van Norman, Gail A.
Publicado: (2021)

One and done: Reasons principal investigators conduct only one FDA-regulated drug trial
por: Corneli, Amy, et al.
Publicado: (2017)

Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learned
por: Hanley, Daniel F., et al.
Publicado: (2023)

Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective
por: de Jong, Amos J., et al.
Publicado: (2022)

Decentralized clinical trials (DCTs): A few ethical considerations
por: Petrini, Carlo, et al.
Publicado: (2022)

Stakeholders’ recommendations for revising Good Clinical Practice
por: Corneli, Amy, et al.
Publicado: (2021)

CRAFT—A Proposed Framework for Decentralized Clinical Trials Participation in Canada
por: Sundquist, Stephen, et al.
Publicado: (2021)

Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion
por: Goodson, Noah, et al.
Publicado: (2022)

76 Methods and Perceptions of Success for Patient Recruitment in Decentralized Clinical Trials
por: Tafuto, Barbara, et al.
Publicado: (2023)

Applying Systems Thinking to Inform Decentralized Clinical Trial Planning and Deployment
por: Betcheva, Lidia, et al.
Publicado: (2023)

Key criteria for considering decentralization in municipal wastewater management
por: Bernal, Diana, et al.
Publicado: (2021)

Remote and semi-automated methods to conduct a decentralized randomized clinical trial
por: Cafaro, Teresa, et al.
Publicado: (2023)

Leveraging patient‐centric sampling for clinical drug development and decentralized clinical trials: Promise to reality
por: Maass, Katie F., et al.
Publicado: (2022)

eP187: Decentralization of clinical trials in the era of COVID-19: Implications for rare disease trials
por: Manjrekar, Kriti, et al.
Publicado: (2022)

Anæsthetics Medico-Legally Considered
por: Johnson, J. G.
Publicado: (1882)

Digital health technologies and Alzheimer’s disease clinical trials: might decentralized clinical trials increase participation by people with cognitive impairment?
por: Leroy, Victoire, et al.
Publicado: (2023)

Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptoms
por: Huh, Ki Young, et al.
Publicado: (2023)

Legal protection of the rights of clinical trial subjects in China
por: Ren, Yuanpeng, et al.
Publicado: (2018)

On the Definition of Insanity Considered Medico-Legally
por: Rorie, James
Publicado: (1865)

New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown
por: Dunlap, Denise, et al.
Publicado: (2020)

Impact of Using A Mixed Data Collection Modality on Statistical Inferences in Decentralized Clinical Trials
por: Curtis, Alexandra, et al.
Publicado: (2022)

Application of Internet of Medical/Health Things to Decentralized Clinical Trials: Development Status and Regulatory Considerations
por: Sato, Takahiro, et al.
Publicado: (2022)

First experience of a fully decentralized clinical trial: The dawn of a new era in oncology
por: Taniguchi, Hiroya, et al.
Publicado: (2023)

Internet Versus Noninternet Participation in a Decentralized Clinical Trial: Lessons From the ADAPTABLE Study
por: Shen, Rebecca, et al.
Publicado: (2023)

Towards a conceptual framework for addressing state-level barriers to decentralized clinical trials in the U.S.
por: Zawada, Stephanie J., et al.
Publicado: (2023)

Considering Usual Medical Care in Clinical Trial Design
por: Dawson, Liza, et al.
Publicado: (2009)

Sequential stages of clinical trials and overview of issues to be considered
por: Clemens, John D., et al.
Publicado: (2005)

Clinical Trials for Treatment of Aphasia: Some Issues to Consider
por: Prasad, Kameshwar
Publicado: (2020)

Despite negative perceptions of clinical trial conduct during the coronavirus disease 2019 (COVID-19) pandemic, are decentralized clinical trial methods here to stay?
por: Cooper, Lisa, et al.
Publicado: (2023)

Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project
por: Perez, Raymond P, et al.
Publicado: (2016)

Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients
por: de las Heras, Begoña, et al.
Publicado: (2022)

Association of Remote Technology Use and Other Decentralization Tools With Patient Likelihood to Enroll in Cancer Clinical Trials
por: Adams, Devon V., et al.
Publicado: (2022)

Empowering clinical research in a decentralized world
por: De Brouwer, Walter, et al.
Publicado: (2021)

Decentralized Platoon Join-in-Middle Protocol Considering Communication Delay for Connected and Automated Vehicle
por: Lee, Geonil, et al.
Publicado: (2021)

Developing core outcome sets for clinical trials: issues to consider
por: Williamson, Paula R, et al.
Publicado: (2012)

Improving community participation in clinical trials in Ghana; factors to consider
por: Appeaning, Mark, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ufhjc1n90ga0p52pmal084tqoq